{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:53:58Z","timestamp":1786996438480,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.rvsc.2020.07.015","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:26:11Z","timestamp":1595589971000},"page":"379-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Toxicity of a methotrexate metronomic schedule in Wistar rats"],"prefix":"10.1016","volume":"132","author":[{"given":"Mar\u00eda Luc\u00eda","family":"Correal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise Carla","family":"Camplesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Abrah\u00e3o","family":"Anai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Henrique Leal","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemeri de Oliveira","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ureo Evangelista","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2020.07.015_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/CMR.11.2.231","article-title":"Natural pathogens of laboratory mice, rats, and rabbits and their effects on research","volume":"11","author":"Baker","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0010","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cvsm.2014.05.003","article-title":"Metronomic chemotherapy in veterinary patients with cancer","volume":"44","author":"Biller","year":"2014","journal-title":"Vet. Clin. N. Am. \u2013 Small."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrclinonc.2016.64","article-title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","volume":"13","author":"Bocci","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.32635\/2176-9745.RBC.2014v60n3.945","article-title":"Biosseguran\u00e7a na Central de Quimioterapia: o Enfermeiro frente ao Risco Qu\u00edmico","volume":"60","author":"Borges","year":"2014","journal-title":"Rev. Bras. Cancerol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0025","series-title":"Annals of the World Toxicological Pathology Congress. Sao Paulo, Brazil. April 21st to 26th 2018","first-page":"14","article-title":"Toxicity of metronomic methotrexate in Wistar rats","author":"Camplesi","year":"2018"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0102-86502012000300002","article-title":"Facial symmetry evaluation after experimentally displaced condylar process fracture in methotrexate treated rats","volume":"27","author":"Cavalcanti","year":"2012","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1593\/neo.131910","article-title":"Intermittent metronomic drug schedule is essential for activating antitumor innate immunity and tumor xenograft regression","volume":"16","author":"Chen","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1382-6689(00)00041-7","article-title":"Cytogenetic toxicity of methotrexate in mouse bone marrow","volume":"8","author":"Choudhury","year":"2000","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/annonc\/mdf013","volume":"13","author":"Colleoni","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.21615\/cesmvz.12.3.3","article-title":"Metronomic therapy to manage the veterinary patient with cancer","volume":"12","author":"Correal Su\u00e1rez","year":"2017","journal-title":"Ces. Med. Vet. Zootec."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0055","first-page":"72","article-title":"Accidental methotrexate ingestion in a dog","volume":"65","author":"Dank","year":"2010","journal-title":"Isr. J. Vet. Med."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jat.1592","article-title":"Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies","volume":"31","author":"Eichenbaum","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0065","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1158\/0008-5472.CAN-04-0580","article-title":"A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens","volume":"64","author":"Emmenegger","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2008.09.014","article-title":"Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment","volume":"44","author":"Fan","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2011.06.040","article-title":"Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer","volume":"48","author":"Fedele","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0080","first-page":"1","article-title":"The reporting of clinical signs in laboratory animals","volume":"0","author":"Fentener van Vlissingen","year":"2015","journal-title":"Lab. Anim-UK."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0085","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/vco.12309","article-title":"The use of low-dose metronomic chemotherapy in dogs -insight into a modern cancer field","volume":"16","author":"Gaspar","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0095","first-page":"529","article-title":"Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma","volume":"32","author":"Gebbia","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4 +CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0105","article-title":"Clinical laboratory parameters for Crl\u00a0: WI (Han) rats","volume":"14","author":"Giknis","year":"2008","journal-title":"Charles River"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.critrevonc.2015.01.008","article-title":"Metronomic chemotherapy from rationale to clinical studies: a dream or reality?","volume":"95","author":"Gnoni","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI9872","article-title":"Less is, more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice","volume":"105","author":"Hanahan","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0120","series-title":"National Research Council","article-title":"Guide for the care and use of laboratory animals","author":"ILAR (Institute for Laboratory Animal Research)","year":"2011"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0041-008X(77)90173-9","article-title":"The effect of repeated oral dosing of methotrexate on its intestinal absorption in the rat","volume":"39","author":"Jolly","year":"1977","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0130","first-page":"3893","article-title":"Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: a retrospective analysis at a single institution","volume":"9","author":"Jung","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0135","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/ijms18102134","article-title":"A combination of immune checkpoint inhibition with metronomic chemotherapy as a way of targeting therapy-resistant cancer cells","volume":"18","author":"Kareva","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","article-title":"The anti-angiogenic basis of metronomic chemotherapy","volume":"4","author":"Kerbel","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/annonc\/mdf093","article-title":"Continuous low-dose-anti-angiogenic\/metronomic chemotherapy: from the research laboratory into the oncology clinic","volume":"13","author":"Kerbel","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0150","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.autrev.2014.08.027","article-title":"Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients","volume":"13","author":"Kivity","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000487629","article-title":"Explorative analysis of low-dose metronomic chemotherapy with cyclophosphamide and methotrexate in a cohort of metastatic breast cancer patients","volume":"13","author":"Krajnak","year":"2018","journal-title":"Breast Care"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0160","series-title":"AVMA Guidelines for the Euthanasia of Animals: 2013 Edition","first-page":"102","author":"Leary","year":"2013"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0165","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.ejca.2013.06.038","article-title":"Low-dose metronomic chemotherapy: a systematic literature analysis","volume":"49","author":"Lien","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.emc.2013.09.002","article-title":"An approach to chemotherapy - associated toxicity","volume":"32","author":"Livshits","year":"2014","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0175","first-page":"1","article-title":"Low-dose \u201cmetronomic chemotherapy\u201d with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit","volume":"6","author":"Masci","year":"2012","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4049\/jimmunol.1700453","article-title":"Of mice, dirty mice, and men: using mice to understand human immunology","volume":"199","author":"Masopust","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0185","first-page":"FC09","article-title":"Metronomic chemotherapy: seems prowess to battle against cancer in current scenario","volume":"10","author":"Muthusamy","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0190","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cvsm.2007.07.002","article-title":"Chemotherapy: new uses for old drugs","volume":"37","author":"Mutsaers","year":"2007","journal-title":"Vet. Clin. N. Am. Small."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2018.06.002","article-title":"Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data","volume":"432","author":"Natale","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0200","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41416-018-0076-z","article-title":"Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma","volume":"118","author":"Orecchioni","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tvjl.2016.03.009","article-title":"Veterinary oncology: biology, big data and precision medicine","volume":"213","author":"Pang","year":"2016","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","article-title":"Metronomic chemotherapy: new rationale for new directions","volume":"7","author":"Pasquier","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0215","doi-asserted-by":"crossref","first-page":"489","DOI":"10.14202\/vetworld.2014.489-495","article-title":"Subacute toxicopathological studies of methotrexate in Wistar rats","volume":"7","author":"Patel","year":"2014","journal-title":"Vet. World"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0220","first-page":"1","article-title":"Phase I\/II study of palliative triple metronomic chemotherapy in platinum-refractory\/early-failure oral cancer","volume":"1","author":"Patil","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2011.04.009","article-title":"Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?","volume":"82","author":"Penel","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cvsm.2011.10.001","article-title":"Bone marrow Cytologic and histologic biopsies: indications, technique, and evaluation","volume":"42","author":"Raskin","year":"2012","journal-title":"Vet.Clin. N. Am. Small."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2014.04.002","article-title":"Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer","volume":"349","author":"Shi","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0245","article-title":"Metronomic cyclophosphamide and methotrexate chemotherapy combined with 1E10 anti-idiotype vaccine in metastatic breast cancer","volume":"710292","author":"Soriano","year":"2011","journal-title":"Int. J. Breast Cancer"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0250","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejphar.2014.06.038","article-title":"Methotrexate causes a change in intestinal 5-hydroxytryptamine metabolism in rats","volume":"740","author":"Takano","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11523-009-0108-y","article-title":"Maximum tolerated dose: clinical endpoint for a bygone era?","volume":"4","author":"Takimoto","year":"2009","journal-title":"Target. Oncol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0260","series-title":"Manual de t\u00e9cnicas para histologia normal e patol\u00f3gica","author":"Tolosa","year":"2003"},{"key":"10.1016\/j.rvsc.2020.07.015_bb0265","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4161\/cbt.5.6.2659","article-title":"Oral ingestion of Streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats","volume":"5","author":"Tooley","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1593\/tlo.13481","article-title":"Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma","volume":"6","author":"Torimura","year":"2013","journal-title":"Transl. Oncol."},{"issue":"Suppl. 61","key":"10.1016\/j.rvsc.2020.07.015_bb0275","first-page":"S27","article-title":"Methotrexate bioavailability","volume":"28","author":"van Roon","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.rvsc.2020.07.015_bb0280","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<884::AID-IJC19>3.0.CO;2-2","article-title":"Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma","volume":"76","author":"Wunder","year":"1998","journal-title":"Int. J. Cancer"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528820309280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528820309280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:22:54Z","timestamp":1758514974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528820309280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":56,"alternative-id":["S0034528820309280"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2020.07.015","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity of a methotrexate metronomic schedule in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2020.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}